| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.22 | 1e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.26 | 2e-06 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-06 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-06 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.16 | 6e-06 |